Supplemental Financial Information (Tables)


		2024		2023		2022
Accounts and notes receivable
Trade receivables		$	8,487	$	8,675
Other receivables		2,202		2,315
Total		10,689		10,990
Allowance, beginning of year		175		150		$	147
Net amounts charged to expense (a)		228		55		21
Deductions		(36)		(26)		(12)
Translation and other		(11)		(4)		(6)
Allowance, end of year		356		175		$	150
Accounts and notes receivable, net		$	10,333	$	10,815







Property, plant and equipment, net	Average Useful Life (Years)
Land		$	1,136	$	1,159
Buildings and improvements	15 - 44	11,938		11,579
Machinery and equipment, including fleet and software	5 - 15	36,990		36,006
Construction in progress		5,941		5,695
		56,005		54,439
Accumulated depreciation		(27,997)		(27,400)
Property, plant and equipment, net		$	28,008	$	27,039
Depreciation expense		$	2,945	$	2,714	$	2,523

Other assets
Noncurrent notes and accounts receivable		$	111	$	200
Deferred marketplace spending		100		103
Pension plans (b)		1,190		1,057
Right-of-use assets (c)		3,383		2,905
Other investments (d)		1,346		1,616
Other		821		780
Total		$	6,951	$	6,661



Accounts payable and other current liabilities
Accounts payable (e)		$	10,997	$	11,635
Accrued marketplace spending		3,458		3,523
Accrued compensation and benefits		2,256		2,687
Dividends payable		1,885		1,767
Current lease liabilities		642		556
Other current liabilities		5,216		4,969
Total		$	24,454	$	25,137

(a)Increase primarily reflects an allowance for expected credit losses related to outstanding receivables from TBG associated with the Juice Transaction; see Note 1 for further information.

(b)See Note 7 for further information.

(c)See Note 12 for further information.

(d)Includes our investment in Celsius convertible preferred stock. See Note 9 for further information.

(e)Primarily reflects a decrease in capital expenditure payables, currency translation adjustments, as well as timing of payments.

Statement of Cash Flows


	2024		2023		2022
Interest paid (a)	$	1,585	$	1,401	$	1,043
Income taxes paid, net of refunds (b)	$	3,064	$	2,532	$	2,766

(a)2022 excludes the premiums paid in accordance with certain debt transactions. See Note 8 for further information.

(b)Includes tax payments of $579 million in 2024, and $309 million in each of 2023 and 2022, related to the TCJ Act.

Supplemental Non-Cash Activity


	2024		2023		2022
Debt discharged via legal defeasance	$	—	$	94	$	—

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:


	2024		2023
Cash and cash equivalents	$	8,505	$	9,711

Restricted cash included in other assets (a)	48		50
Total cash and cash equivalents and restricted cash	$	8,553	$	9,761

(a)Primarily relates to collateral posted against certain of our derivative positions.